Morning Market Losers By: Benzinga via Benzinga September 29, 2014 at 09:48 AM EDT Tonix Pharmaceuticals Holding (NASDAQ: TNXP) shares dropped 55.09% to $6.27 after the company reported Phase 2b BESTFIT trial of TNX-102 ... Read More >> Related Stocks: Cyberark Soft Ord Endologix Inc Karyopharm Therapeut Mattel Sabra REIT